Sort
39,280 grants matching “leukemia”
Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics
$730,587Alexander Sparreboom · Ohio State University · R01 · FY2024 · HL
NexTGen - STANFORD
$730,473Irving Lerner Weissman · Stanford University · OT2 · FY2022 · CA
Diazeniumdiolates as Broad-Spectrum Anticancer Agents
$730,343Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Combining Targeted RIT and Synergistic Novel Agents to Eradicate AML
$730,303Johnnie Jose Orozco · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
Computational Tools For Bioinformatics And Genome Analysis
$730,091John I Powell · Center For Information Technology · ZIA · FY2009 · CT
Hematopoietic Stem Cell And Cord Blood Transplantation
$729,767Effie W Petersdorf · Fred Hutchinson Cancer Center · U01 · FY2022 · AI
Multiscale Modeling of Myelodysplastic Syndromes
$729,676Seth Joel Corey · Virginia Commonwealth University · R01 · FY2017 · HL
DNMT3A in Development of Hematologic Malignancies
$729,528Margaret Goodell · Baylor College Of Medicine · R01 · FY2020 · CA
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$729,420William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2018 · GM
Prevalence and persistence of the ETV6/RUNX1 pre-leukemic clone
$729,403Erin Marcotte · University Of Minnesota · R01 · FY2024 · CA
Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy
$729,130Navin Varadarajan · University Of Houston · R01 · FY2012 · CA
Administrative Core
$729,023Steven Piantadosi · Brigham And Women'S Hospital · U10 · FY2023 · CA
Control Of G Protein Signaling: Role Of The RGSs
$728,921John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Exploiting mouse models of pediatric cancers and epigenetics for therapy
$728,812Stuart H Orkin · Dana-Farber Cancer Inst · U01 · FY2013 · CA
Wnt signaling in hematopoietic development
$728,660David Traver · University Of California, San Diego · R01 · FY2021 · HL
The physiological and molecular function of choline transport in health and metabolic disease
$728,531Kivanc Birsoy · Rockefeller University · R01 · FY2025 · DK
Personalized Adoptive T-cell Therapy for AML
$728,501David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity
$728,478Zachary Graham Forbes · Celldom, Inc. · R44 · FY2019 · GM
Lymphoma Studies
$728,259Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Genetic Aspects Of Viral Oncogenesis In Wild Mouse Species
$728,119Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging
$728,079Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Wnt signaling in hematopoietic development
$728,003David Traver · University Of California, San Diego · R01 · FY2022 · HL
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$727,832Anupriya Agarwal · Oregon Health & Science University · U54 · FY2017 · CA
Genetics and Signaling of Drug Resistance and Sensitivity in AML Cell Lines, Xenografts, and Primary Patient Samples
$727,832Anupriya Agarwal · Oregon Health & Science University · U54 · FY2017 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins
$727,816Stephanie L. Schmit · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA